Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2024 financial results after market close on...

Related Keywords

California ,United States ,South San Francisco ,David Rosen ,Nasdaq ,Rigel Pharmaceuticals Inc ,Prnewswire Rigel Pharmaceuticals ,Investor Relations ,Rigel Pharmaceuticals ,Nc ,